Page last updated: 2024-08-23

digitoxigenin monodigitoxoside and Lung Neoplasms

digitoxigenin monodigitoxoside has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa, LA; Braga, FC; Cortes, VF; Kreis, W; Munkert, J; Pádua, RM; Persich, L; Ramos, ACP; Rocha, SC; Schneider, NFZ; Silva, IT; Simões, CMO; Taranto, AG1
Braga, FC; Geller, FC; Kreis, W; Marostica, LL; Pádua, RM; Persich, L; Schneider, NF; Simões, CM1

Other Studies

2 other study(ies) available for digitoxigenin monodigitoxoside and Lung Neoplasms

ArticleYear
Cytotoxic and cytostatic effects of digitoxigenin monodigitoxoside (DGX) in human lung cancer cells and its link to Na,K-ATPase.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Digitoxigenin; Humans; Lung Neoplasms; Molecular Docking Simulation; Sodium-Potassium-Exchanging ATPase; Swine; Time Factors

2018
Inhibition of cell proliferation, invasion and migration by the cardenolides digitoxigenin monodigitoxoside and convallatoxin in human lung cancer cell line.
    Natural product research, 2016, Volume: 30, Issue:11

    Topics: A549 Cells; Cardenolides; Cardiac Glycosides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Digitoxigenin; Humans; Lung Neoplasms; Neoplasm Metastasis; Strophanthins

2016